- 1) Ludlow, J. W., Interactions between SV40 large-tumor antigen and the growth suppresser proteins pRB and p53. FASEB J., 7, 866-871 (1993).
- 2) Barbosa, M. S., The oncogenic role of human papillomavirus proteins. Crit. Rev. Oncog., 7, 1-18 (1996)
- 3) Counter, C. M., Avillon, A. A., Lefeuvre, C. E., Stewart, N. G., Greider, C. W., Harley, C. B., and Bacchetti, S., Telomere shortening in SV40 transformed cells. EMBO J., 11, 1921-1929 (1992).
- 4) Nakabayashi, K., Ogata, T., Fujii, M., Tahara, H., Ide, T., Wadhwa, R., Kaul, S. C., Mitsui, Y., and Ayusawa, D., Decrease in amplified telomeric sequences and induction of senescence markers by introduction of human chromosome 7 or its segments in SUSM-1. Exp. Cell Res., 235, 345-53 (1997).
- 5) Southern, P. J. and Berg, P., Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J. Mol. Appl. Genet., 1, 327-341 (1982).
- 6) Watanabe, S., Kanda, T., and Yoshiike, K., Human papillomavirus type 16 transformation of primary human embryonic fibroblasts requires expression of open reading frames E6 and E7. J Virol., 63, 965-969 (1989).
- 7) Hirano, Y., Tsutsumi-Ishii, Y., and Tsuchida, N., Roles of p53 mutation in cell line establishment and identification of the minimum transactivation and transform suppression domains. Eur. J. Cancer B. Oral Oncol., 2, 129-135 (1995).
- 8) El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B., WAF1, a potential mediator of p53 tumor suppression. Cell, 75, 817-825 (1993).
- 9) Gottlieb, T. M. and Oren, M., p53 in growth control and neoplasia. Biochim Biophys Acta., 1287, 77-102 (1996).
- 10) Smith, J. R., Nakanishi, M., Robetorye, R. S., Venable, S. F., Pereira-Smith, O. M., Studies demonstrating the complexity of regulation and action of the growth inhibitory gene SDI1. Exp. Gerontol., 31, 327-335 (1996).
Full access
Suppression of Senescence in Normal Human Fibroblasts by Introduction of Dominant-Negative p53 Mutants or Human Papilloma Virus Type 16 E6 Protein
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.